Subtype I (intrinsic) adenomyosis is an independent risk factor for dienogest-related serious unpredictable bleeding in patients with symptomatic adenomyosis | Scientific Reports
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research suggests that subtype i adenomyosis may be linked to an increased risk of serious unpredictable bleeding in patients with symptomatic adenomyosis who are treated with dienogest. This subtype of adenomyosis is reported to be an independent risk factor for such bleeding. The findings indicate a potential connection between the specific type of adenomyosis and the likelihood of bleeding complications with dienogest treatment.